Insmed
INSM
#542
Rank
HK$338.69 B
Marketcap
HK$1,588
Share price
-0.51%
Change (1 day)
170.91%
Change (1 year)

Insmed (INSM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : HK$11.01 Billion

According to Insmed's latest financial reports the company's total liabilities are HK$11.01 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Insmed - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31HK$13.50 B4.08%
2023-12-31HK$12.97 B5.9%
2022-12-31HK$12.25 B88.66%
2021-12-31HK$6.49 B61.05%
2020-12-31HK$4.03 B7.75%
2019-12-31HK$3.74 B20.62%
2018-12-31HK$3.10 B293.31%
2017-12-31HK$0.78 B21.89%
2016-12-31HK$0.64 B86.17%
2015-12-31HK$0.34 B0.44%
2014-12-31HK$0.34 B34.56%
2013-12-31HK$0.25 B1.56%
2012-12-31HK$0.25 B485.93%
2011-12-31HK$43.23 M62.33%
2010-12-31HK$26.63 M23.5%
2009-12-31HK$21.56 M-63.19%
2008-12-31HK$58.58 M-6.22%
2007-12-31HK$62.46 M-44.48%
2006-12-31HK$0.11 B17.6%
2005-12-31HK$95.68 M113.17%
2004-12-31HK$44.88 M61.22%
2003-12-31HK$27.84 M-26.54%
2002-12-31HK$37.9 M-59.19%
2001-12-31HK$92.87 M

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Sarepta Therapeutics
SRPT
HK$16.91 B 53.57%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$486.82 B 4,319.05%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Gilead Sciences
GILD
HK$288.62 B 2,519.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
HK$9.39 B-14.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Aerie Pharmaceuticals
AERI
HK$4.20 B-61.87%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
HK$58.72 B 433.05%๐Ÿ‡บ๐Ÿ‡ธ USA